Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Reader Login
  Users Online: 3156Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2020| July-September  | Volume 11 | Issue 3  
    Online since July 6, 2020

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
EDITORIAL
Real-world data in COVID-19 pandemic: An essential unmet health-care need
Arun Bhatt
July-September 2020, 11(3):103-105
DOI:10.4103/picr.PICR_168_20  
  2,676 546 -
ORIGINAL ARTICLE
COVID-19 effect on clinical research: Single-site risk management experience
Fatma Soliman Elsayed Ebeid
July-September 2020, 11(3):106-110
DOI:10.4103/picr.PICR_119_20  
  2,643 507 1
SPONSOR STRATEGIES
Challenges and opportunities for sponsors in conducting clinical trials during a pandemic
Sanish Davis, Seema Pai
July-September 2020, 11(3):115-120
DOI:10.4103/picr.PICR_177_20  
  2,562 421 -
INVESTIGATOR INSIGHTS
Addressing challenges due to the COVID-19 pandemic – A site and investigator perspective
Priya Ranganathan, Deepa Nair, Nithya Jaideep Gogtay
July-September 2020, 11(3):111-114
DOI:10.4103/picr.PICR_165_20  
  2,499 471 -
MEDICAL AFFAIRS
Medical affairs post-COVID 19: Are we ready to take the baton?
Viraj Deodatta Rajadhyaksha
July-September 2020, 11(3):124-127
DOI:10.4103/picr.PICR_164_20  
  1,400 313 -
PHARMACOVIGILANCE PERSPECTIVES
Pharmacovigilance and assessment of drug safety reports during COVID 19
Mira K Desai
July-September 2020, 11(3):128-131
DOI:10.4103/picr.PICR_171_20  
  778 210 -
REGULATORY UPDATE
Indian regulatory update during the COVID-19 pandemic
Amita Chandan Bhave
July-September 2020, 11(3):132-134
DOI:10.4103/picr.PICR_182_20  
  777 198 -
ETHICS EDUCATION
Ethics committee meetings – Online or face to face?
Ravindra Bhaskar Ghooi
July-September 2020, 11(3):121-123
DOI:10.4103/picr.PICR_97_20  
  491 136 -
LETTER TO EDITOR
Prerequisite of doing clinical trial with drugs in COVID-19 patients: Situational experience
Pugazhenthan Thangaraju, Atul Jindal
July-September 2020, 11(3):135-135
DOI:10.4103/picr.PICR_184_20  
  249 78 -
  Feedback 
  Subscribe